Sol-Gel Technologies (SLGL) Shares Outstanding (Diluted Average) (2019 - 2025)

Sol-Gel Technologies (SLGL) reported Shares Outstanding (Diluted Average) of $2.8 million for Q4 2025, little changed year-over-year from $2.8 million in Q4 2024, and little changed quarter-over-quarter from $2.8 million in Q2 2025.

Sol-Gel Technologies (SLGL) Shares Outstanding (Diluted Average) (2019 - 2025) Analysis & Trends

Sol-Gel Technologies (SLGL) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $2.8 million in Q4 2025.

  • Shares Outstanding (Diluted Average) for Q4 2025 came in at $2.8 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (changed 0.0% YoY), and the FY2025 annual result was $2.8 million, changed 0.0% from the prior year.
  • Shares Outstanding (Diluted Average) steadied at $2.8 million in Q4 2025 per SLGL's latest filing, from $2.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $27.7 million in Q2 2023 and troughed at $2.7 million in Q4 2023.
  • A 5-year average of $13.4 million and a median of $12.9 million in 2021 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) rose 19.59% in 2023, then tumbled 89.93% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $23.6 million in 2021, then declined by 1.86% to $23.1 million in 2022, then sank by 88.29% to $2.7 million in 2023, then increased by 2.85% to $2.8 million in 2024, then gained by 0.0% to $2.8 million in 2025.
  • Business Quant data shows SLGL's Shares Outstanding (Diluted Average) at $2.8 million in Q4 2025, $2.8 million in Q2 2025, and $2.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.79 Mn
Jun 30, 2025 2.79 Mn
Dec 31, 2024 2.79 Mn
Jun 30, 2024 2.79 Mn
Dec 31, 2023 2.71 Mn
Jun 30, 2023 27.66 Mn
Dec 31, 2022 23.13 Mn
Jun 30, 2022 23.13 Mn
Dec 31, 2021 23.57 Mn
Jun 30, 2021 23.03 Mn
Dec 31, 2020 22.57 Mn
Dec 31, 2019 19.53 Mn